Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy

Z Baloch, A J Prestipino, U L Seinige, B A Mason, D M Sataloff, C P Lieber, Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. Journal of The American College of Surgeons. ,vol. 180, pp. 297- 306 ,(1995)

Mary K. Gospodarowicz, Leslie H. Sobin, C. Wittekind, Comprar TNM Classification of Malignant Tumours, 7th Edition | C. Wittekind | 9781444332414 | Wiley Wiley. ,(2009)

Nicholas Turner, Andrew Tutt, Alan Ashworth, Hallmarks of 'BRCAness' in sporadic cancers Nature Reviews Cancer. ,vol. 4, pp. 814- 819 ,(2004) , 10.1038/NRC1457

TNM classification of malignant tumours Published in <b>2010</b> in Chichester, West Sussex, UK ;Hoboken, NJ by Wiley-Blackwell. ,(1987) , 10.1007/978-3-642-82982-6

Andrew Tutt, Paul Ellis, Lucy Kilburn, Cheryl Gilett, Sarah Pinder, Jacinta Abraham, Sophie Barrett, Peter Barrett-Lee, Stephen Chan, Maggie Cheang, Mitch Dowsett, Lisa Fox, Patrycja Gazinska, Anita Grigoriadis, Alexander Gutin, Catherine Harper-Wynne, Matthew Hatton, Sarah Kernaghan, Jerry Lanchbury, James Morden, Julie Owen, Jyoti Parikh, Peter Parker, Nazneen Rahman, Rebecca Roylance, Adam Shaw, Ian Smith, Rose Thompson, Kirsten Timms, Holly Tovey, Andrew Wardley, Gregory Wilson, Mark Harries, Judith Bliss, Abstract S3-01: The TNT trial: A randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative orBRCA1/2breast cancer (CRUK/07/012) Cancer Research. ,vol. 75, ,(2015) , 10.1158/1538-7445.SABCS14-S3-01

Christos Hatzis, W. Fraser Symmans, Ya Zhang, Rebekah E. Gould, Stacy L. Moulder, Kelly K. Hunt, Maysa Abu-Khalaf, Erin W. Hofstatter, Donald Lannin, Anees B. Chagpar, Lajos Pusztai, Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer. Clinical Cancer Research. ,vol. 22, pp. 26- 33 ,(2016) , 10.1158/1078-0432.CCR-14-3304

Elena Provenzano, , Veerle Bossuyt, Giuseppe Viale, David Cameron, Sunil Badve, Carsten Denkert, Gaëtan MacGrogan, Frédérique Penault-Llorca, Judy Boughey, Giuseppe Curigliano, J Michael Dixon, Laura Esserman, Gerd Fastner, Thorsten Kuehn, Florentia Peintinger, Gunter von Minckwitz, Julia White, Wei Yang, W Fraser Symmans, Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer : recommendations from an international working group Modern Pathology. ,vol. 28, pp. 1185- 1201 ,(2015) , 10.1038/MODPATHOL.2015.74

Jennet M. Harvey, Gary M. Clark, C. Kent Osborne, D. Craig Allred, Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer Journal of Clinical Oncology. ,vol. 17, pp. 1474- 1474 ,(1999) , 10.1200/JCO.1999.17.5.1474

G Bonadonna, P Valagussa, C Brambilla, L Ferrari, A Moliterni, M Terenziani, M Zambetti, Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. Journal of Clinical Oncology. ,vol. 16, pp. 93- 100 ,(1998) , 10.1200/JCO.1998.16.1.93

B Fisher, A Brown, E Mamounas, S Wieand, A Robidoux, R G Margolese, A B Cruz, E R Fisher, D L Wickerham, N Wolmark, A DeCillis, J L Hoehn, A W Lees, N V Dimitrov, Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. Journal of Clinical Oncology. ,vol. 15, pp. 2483- 2493 ,(1997) , 10.1200/JCO.1997.15.7.2483